Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Child-Pugh A Hepatocellular Carcinoma”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)Study completedNCT02151864
What this trial is testing

LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Jason K. Sicklick, M.D. 9
Testing effectiveness (Phase 2)Study completedNCT03109886
What this trial is testing

Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tiziana Life Sciences LTD 31
Testing effectiveness (Phase 2)Ended earlyNCT01097083
What this trial is testing

Coriolus Versicolor as Palliative Therapy Compared to Placebo in Patients With Child-Pugh C Unresectable Hepatocellular Carcinoma

Who this might be right for
CarcinomaTherapy
National University Hospital, Singapore 20
Testing effectiveness (Phase 2)Study completedNCT05622071
What this trial is testing

Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
UNICANCER 50
Early research (Phase 1)Ended earlyNCT03059147
What this trial is testing

Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
SignalRX Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07514455
What this trial is testing

Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients

Who this might be right for
Carcinoma, HepatocellularHepatic InsufficienDisease Progression+1 more
Ju Hyun Shim 20
Testing effectiveness (Phase 2)Study completedNCT03211416
What this trial is testing

Sorafenib Tosylate and Pembrolizumab in Treating Patients With Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Adult Hepatocellular CarcinomaChild-Pugh Class AStage III Hepatocellular Carcinoma+6 more
Roswell Park Cancer Institute 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT06096779
What this trial is testing

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

Who this might be right for
Hepatocellular Carcinoma
Genentech, Inc. 30
Large-scale testing (Phase 3)Looking for participantsNCT06007846
What this trial is testing

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Inova Health Care Services 12
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Early research (Phase 1)Not Yet RecruitingNCT06994572
What this trial is testing

Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Captor Therapeutics S.A. 141
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297654
What this trial is testing

First-Line Lenvatinib in Child-Pugh B Patients With HCC Unsuitable for Curative Treatment

Who this might be right for
Advanced Hepatocellular Carcinoma
National Cancer Center, Korea 50
Early research (Phase 1)WithdrawnNCT02989870
What this trial is testing

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Who this might be right for
HepatoCellular CarcinomaUnresectable HepatoCellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)UnknownNCT04454762
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function

Who this might be right for
Hepatocellular Carcinoma
Johannes Gutenberg University Mainz 20
Early research (Phase 1)Study completedNCT01839604
What this trial is testing

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic
AstraZeneca 58
Testing effectiveness (Phase 2)Study completedNCT01232296
What this trial is testing

Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)Looking for participantsNCT05201404
What this trial is testing

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Can-Fite BioPharma 471
Testing effectiveness (Phase 2)Study completedNCT00073736
What this trial is testing

Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ligand Pharmaceuticals 28
Testing effectiveness (Phase 2)Study completedNCT02128958
What this trial is testing

Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Can-Fite BioPharma 78
Testing effectiveness (Phase 2)Study completedNCT02115373
What this trial is testing

C-Met Second-Line Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 66
Next Page